Population characteristics | Overall patients No. (%) | Died from RCC No. (%) | Died from other cause No. (%) | P-value |
---|---|---|---|---|
All patients | 107,683(100%) | 25,376(100%) | 27,178(100%) | |
Age(years) | ||||
Median age (25th–75th percentile) | 62(52–72) | 67.5(57.5–77.5) | 72(62–77.5) | < 0.001 |
Mean age | 63.42 | 65.971 | 69.598 | 0.003 |
Sex | < 0.001 | |||
Female | 40,363(37.5%) | 8715(34.3%) | 9963(36.7%) | |
Male | 67,320(62.5%) | 16,661(65.7%) | 17,215(63.3%) | |
Race | < 0.001 | |||
White | 87,915(81.6%) | 21,063(83.0%) | 22,096(81.3) | |
Black | 10,124(9.4%) | 2158(8.5%) | 3228(11.9%) | |
Othersa | 9644(9.0%) | 2155(8.5%) | 1854(6.8%) | |
Summary stage | < 0.001 | |||
Localized | 57,712(53.6%) | 5376(21.2%) | 18,560(68.3%) | |
Regional | 14,615(13.6%) | 5247(20.7%) | 3979(14.6%) | |
Distant | 15,002(13.9%) | 12,003(47.3%) | 2141(7.9%) | |
Unknown | 20,354(18.9%) | 2750(10.8%) | 2498(9.2%) | |
Undergoing surgery | < 0.001 | |||
Yes | 85,304(79.2%) | 13,865(54.6%) | 20,381(75.0%) | |
No | 21,778(20.2%) | 11,330(44.6%) | 6613(24.3%) | |
Unknown | 601(0.6%) | 181(0.7%) | 184(0.7%) | |
Chemotherapy | < 0.001 | |||
Yes | 6744(6.3%) | 4659(18.4%) | 774(2.8%) | |
No | 100,939(93.7%) | 20,717(81.6%) | 26,404(97.2%) | |
Cause of death | ||||
RCC | 25,376(23.6%) | 25,376(100%) | 0(0%) | NA |
Non-disease cause | 4023(3.7%) | 0(0%) | 4023(14.8%) | |
Other cancers | 8003(7.4%) | 0(0%) | 8003(29.4%) | |
Non-cancer disease | 4195(3.9%) | 0(0%) | 4195(15.4%) | |
Cardiovascular diseases | 9023(8.4%) | 0(0%) | 9023(33.2%) | |
Respiratory diseases | 1934(1.8%) | 0(0%) | 1934(7.1%) | |
Censoreda | 55,129(51.2%) | 0(0%) | 0(0%) | |
Median survival month (25th–75th percentile) | 50(14–113) | 12 (3–39) | 55(17–112) | < 0.001 |
Mean survival month | 72.608 | 30.269 | 72.706 | < 0.001 |